Aspirin, Clopidogrel, and Ticagrelor in Acute Coronary Syndromes

Dual antiplatelet therapy is the cornerstone in the management of patients with acute coronary syndromes (ACS). Ticagrelor, an oral, direct, reversibly binding, P2Y12 receptor antagonist, is approved for the prevention of atherothrombotic events in adult patients with ACS. In the PLATelet inhibition...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2013-09, Vol.112 (5), p.737-745
1. Verfasser:	Berger, Jeffrey S., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome Acute coronary syndromes Adenosine - analogs & derivatives Adenosine - therapeutic use Aspirin Aspirin - therapeutic use Cardiovascular Cardiovascular disease Coronary vessels Dose-Response Relationship, Drug Drug Interactions - physiology Heart attacks Humans Mortality Platelet Aggregation Inhibitors - therapeutic use Purinergic P2Y Receptor Antagonists - therapeutic use Receptors, Purinergic P2Y12 Secondary Prevention - methods Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!